1
by Marchand, Dave K., Loshak, Hannah
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Canada...

3
by Marchand, Dave K., McCormack, Suzanne
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Canada...

4
by Marchand, Dave K., Farrah, Kelly
Published 2019
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Canada...

5
by Marchand, Dave K., McCormack, Suzanne
Published 2020
Canadian Agency for Drugs and Technologies in Health
Subjects: ...Canada...

7
by Marchand, Dave K., Farrah, Kelly
Published 2019
Canadian Agency for Drugs and Technologies in Health
..., in order to restore blood flow. In Canada, the thrombolytics alteplase and tenecteplase are currently...

8 ... of antidiabetic agents are approved in Canada: insulins, sulphonylureas (SUs), α-glucosidase inhibitors...

9 ... of antidiabetic agents are approved in Canada: insulins, sulphonylureas (SUs), α-glucosidase inhibitors...